Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03395366 · ClinicalTrials.gov registry record · NA
Improving Outcomes for Hemodialysis Patients
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT03395366 is a NA study that has completed, run by Columbia University. The registered enrollment target is 48 participants.
The verdict
NCT03395366, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
End stage renal disease (ESRD) affects approximately 700,000 Americans of which approximately 400,000 are on life-saving hemodialysis therapy. Hemodialysis can take a physical and emotional toll on patients, and most patients on hemodialysis describe poor quality of life. Patients on hemodialysis have worse health related quality of life (HrQOL) than patients with any other chronic illness including cancer and congestive heart failure. This poor quality of life can affect how well these patients manage their own health or their self-care, and can ultimately lead to poor health outcomes. Despite this, there are no commonly used programs to improve quality of life or self-care for patients on hemodialysis. The investigators have developed a simple 3-step program to improve quality of life and self-care for patients on hemodialysis. The first step involves presenting quality of life scores to the dialysis health care team so that a program can be designed. The second step involves 8-12 education sessions combined with behavioral training designed to improve quality of life and self-care. The final step is monthly re-evaluation of progress. In this study, the investigators will test this 3-step program, compared to dialysis education alone, to see if it improves quality of life and self-care. By improving quality of life and self-care the investigators believe patient outcomes including hospitalizations will improve.
Interventions
- OTHER Multifaceted Educational / Cognitive Behavioral Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2020-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03395366
The ClinicalTrials.gov registry entry for NCT03395366 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multifaceted Educational / Cognitive Behavioral Intervention is the first listed.
NCT03395366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03395366 about?
NCT03395366 is a clinical study titled "Improving Outcomes for Hemodialysis Patients". End stage renal disease (ESRD) affects approximately 700,000 Americans of which approximately 400,000 are on life-saving hemodialysis therapy. Hemodialysis can take a physical and emotional toll on patients, and most patients on hemodialysis describe poor quality of life. Patients on hemodialysis ha...
What is the current status of trial NCT03395366?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-05-01. Estimated completion is 2020-04-28.
What interventions are being tested in trial NCT03395366?
The interventions under investigation include: Multifaceted Educational / Cognitive Behavioral Intervention (OTHER).
Who is sponsoring clinical trial NCT03395366?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.